Prevention and management of hearing loss in patients receiving ototoxic medications

Lindeborg, Michael M; Jung, David H; Chan, Dylan K; Mitnick, Carole D.
Bull. W.H.O. (Print) ; 100(12): 789-796A, 2022-12-01.
Artículo en Inglés | WHOLIS | ID: who-365101

Documentos relacionados

  1. Osteonecrosis de los maxilares asociada a bifosfonatos
  2. [Current aspects of ototoxicity : Local ototoxic effects, diagnosis, prevention, and treatment].
  3. Infección fúngica invasora en el trasplante de órgano sólido
  4. Hearing loss in older adults.
  5. N-Acetyl-L-cysteine Affects Ototoxicity Evoked by Amikacin and Furosemide Either Alone or in Combination in a Mouse Model of Hearing Threshold Decrease.
  6. Priorities for hearing loss prevention and estimates of global cause-specific burdens of hearing loss: a systematic rapid review.
  7. Prevention and management of hearing loss in patients receiving ototoxic medications.
  8. Prevalence of aminoglycoside-induced hearing loss in drug-resistant tuberculosis patients: A systematic review.
  9. Evaluation and Management of Patients with Diabetes and Hearing Loss.
  10. Detection of unknown ototoxic adverse drug reactions: an electronic healthcare record-based longitudinal nationwide cohort analysis.